Article thumbnail

Results of endovascular treatment of iliac and femoral symptomatic lesions. Identification of re-intervention risk factors

By Wojciech Stecko, Wojciech Rogala, Marcin Feldo, Marek Ilzecki, Waclaw Karakula, Aleksander Kasprzak and Tomasz Zubilewicz

Abstract

Introduction. The aim of the study was to assess a presence of peripheral arterial disease risk factors in patients with symptomatic femoral and iliac lesions treated with use of Jaguar and Supera nitinol stents and to estimate potential relation between these factors and reintervention rate. Material and methods. The study group consisted of 60 patients between 46 and 85 years of age who presented with typical symptoms of intermittent claudication or critical limb ischemia and underwent percuta­neous transluminal angioplasty with stenting. We examined and divided group into two subgroups — patients who experienced or did not experience need of reintervention in treated lesion. Results. During the follow-up 24 (40%) of patients underwent reintervention in treated artery due to re­current symptoms of disease. Need of target lesion revascularization occurred more frequent in patients with hypertension (OR = 2.5), patient older than 68 (OR = 1.75) and smokers (OR = 1.75). Patency of all three arteries below knee protected from reintervention. Conclusions. Jaguar and Supera self-expanding nitinol stents has several advantages and its use were char­acterized by high procedural success and moderate frequency of reintervention correlated to some clinical findings like hypertension. Further studies are necessary to estimate factors disturbing and interfering with long-term patency.Introduction. The aim of the study was to assess a presence of peripheral arterial disease risk factors in patients with symptomatic femoral and iliac lesions treated with use of Jaguar and Supera nitinol stents and to estimate potential relation between these factors or some angiographical conditions and reintervention rate. Material and methods. The study group consisted of 60 patients between 46 and 85 years of age who presented with typical symptoms of intermittent claudication or critical limb ischemia and underwent percutaneous transluminal angioplasty with stenting using Supera or Jaguar self-expanding nitinol stent. We examined and divided group into two subgroups – patients who experienced or didn’t experience need of reintervention in treated lesion.Results. In 33 patients (55%) nitinol stent Jaguar and in 27 patients (45%) Supera were implanted. During the follow-up 24 of patients (40%) underwent reintervention in treated artery due to recurrent symptoms of disease. Need of target lesion revascularization occurred more frequent in patients with hypertension (OR=2,5), patient older than 68 (OR=1,75) and smokers (OR=1,75). Patency of all three arteries below knee protected from reintervention. Diabetes mellitus type 2, chronic kidney disease, kind or size of implanted stent and antiplatelet therapy model didn’t determine a need of reintervention. Conclusions. Jaguar and Supera self-expanding nitinol stents has several andvantages and its use were characterized by high procedural success and moderate frequency of reintervention correlated to some clinical findings like hypertension. Further studies are necessary to estimate factors disturbing and interfering with long-term patency

Topics: self-expanding nitinol stents, risk factors, revascularization, self-expanding nitinol stents, risk factors, revascularization
Publisher: 'VM Media SP. zo.o VM Group SK'
Year: 2017
DOI identifier: 10.5603/AA.2017.0010
OAI identifier: oai:czasopisma.viamedica.pl:article/54522
Provided by: Via Medica Journals

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.